Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News CV Team Pro

NorthShore University Health System

L.A. McKeown

December 30, 2020

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Daily News

US Cath Labs and COVID-19: Pushed Procedures, Late STEMIs, and Paycheck Pain

Shelley Wood

September 17, 2020

News Daily News

Teamwork Needed to Reduce Stroke and Its Consequences in Cardiac Surgery: AHA

L.A. McKeown

August 26, 2020

News Daily News

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

Todd Neale

August 12, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Daily News

Cardiogenic Shock Spells Poor Outcomes Despite Successful TAVR

Todd Neale

June 02, 2020

News Daily News

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Michael O'Riordan

May 27, 2020

News Conference News ACC 2020

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

L.A. McKeown

April 07, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Conference News STS 2020

Safer, Quicker Discharge With Protocols for Enhanced Recovery After Surgery

Yael L. Maxwell

February 07, 2020

Advertisement

NorthShore University Health System

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

US Cath Labs and COVID-19: Pushed Procedures, Late STEMIs, and Paycheck Pain

Teamwork Needed to Reduce Stroke and Its Consequences in Cardiac Surgery: AHA

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

Cardiogenic Shock Spells Poor Outcomes Despite Successful TAVR

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Safer, Quicker Discharge With Protocols for Enhanced Recovery After Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content